ruthenium has been researched along with nile red in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benadiba, M; Colquhoun, A; de Oliveira Silva, D; Ribeiro, G | 1 |
| Kurihara, R; Son, A; Takagi, K; Tanabe, K; Yoshihara, K | 1 |
2 other study(ies) available for ruthenium and nile red
| Article | Year |
|---|---|
The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; G1 Phase; gamma-Linolenic Acid; Glioma; Membrane Potential, Mitochondrial; Organometallic Compounds; Oxazines; Rats; Reactive Oxygen Species; Ruthenium; Spectrophotometry, Atomic; Staining and Labeling | 2010 |
Aggregate Formation of Oligonucleotides that Assist Molecular Imaging for Tracking of the Oxygen Status in Tumor Tissue.
Topics: A549 Cells; Animals; Coordination Complexes; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Light; Luminescent Agents; Mice, Inbred BALB C; Molecular Imaging; Nitroimidazoles; Oligodeoxyribonucleotides; Oxazines; Oxygen; Pyrenes; Ruthenium; Tumor Hypoxia | 2017 |